Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CVRx (CVRX) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for CVRx (CVRX) over the last 5 years, with Q4 2025 value amounting to $26.1 million.

  • CVRx's Shares Outstanding (Diluted Average) rose 1543.83% to $26.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $26.1 million, marking a year-over-year increase of 1543.83%. This contributed to the annual value of $26.1 million for FY2025, which is 1543.83% up from last year.
  • As of Q4 2025, CVRx's Shares Outstanding (Diluted Average) stood at $26.1 million, which was up 1543.83% from $26.2 million recorded in Q3 2025.
  • CVRx's 5-year Shares Outstanding (Diluted Average) high stood at $26.2 million for Q3 2025, and its period low was $360675.0 during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $20.7 million (2023), whereas its average is $19.4 million.
  • As far as peak fluctuations go, CVRx's Shares Outstanding (Diluted Average) skyrocketed by 557085.08% in 2022, and later surged by 100.77% in 2023.
  • Quarter analysis of 5 years shows CVRx's Shares Outstanding (Diluted Average) stood at $10.4 million in 2021, then skyrocketed by 98.19% to $20.5 million in 2022, then rose by 1.08% to $20.8 million in 2023, then grew by 8.87% to $22.6 million in 2024, then grew by 15.44% to $26.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $26.1 million for Q4 2025, versus $26.2 million for Q3 2025 and $26.1 million for Q2 2025.